2022
DOI: 10.26434/chemrxiv-2022-7f7x2-v2
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Discovery of 1-benzhydryl piperazine-based HDAC inhibitors with anti-cancer and anti-metastatic properties against human breast cancer: synthesis, molecular modeling, in vitro and in vivo biological evaluation

Abstract: Isoform-selective histone deacetylase (HDAC) inhibition is promoted as a rational strategy to develop safer anti-cancer drugs compared to non-selective HDAC inhibitors. Despite this presumed benefit, considerably more non-selective HDAC inhibitors have undergone clinical trials. In this report, we detail the design and discovery of potent HDAC inhibitors with 1-benzhydryl piperazine as a surface recognition group that differ in hydrocarbon linker. Surprisingly, in vitro HDAC screening identified two selective … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
1

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 57 publications
0
1
0
Order By: Relevance
“…19,30 In experimental analysis we have used ROCK1/2 inhibitor RKI-1447 (abbreviated as RKI, IC 50 (ROCK1) = 14.5 nM, and IC 50 (ROCK2) = 6.2 nM), and our recently developed set of HDAC inhibitors: Compound C6 (IC 50 (HDAC1) = 4.73 μM, IC 50 (HDAC3) = 1.86 μM, IC 50 (HDAC6) = 0.19 μM, IC 50 (HDAC8) = 2.44 μM); Compound C8 (IC 50 (HDAC1) = 0.41 μM, IC 50 (HDAC3) = 0.21 μM, IC 50 (HDAC6) = 0.12 μM, IC 50 (HDAC8) = 0.24 μM); Compound C9 (IC 50 (HDAC1) = 1.47 μM, IC 50 (HDAC3) = 3.47 μM, IC 50 (HDAC6) = 0.03 μM, IC 50 (HDAC8) = 0.71 μM). 31…”
Section: Resultsmentioning
confidence: 99%
“…19,30 In experimental analysis we have used ROCK1/2 inhibitor RKI-1447 (abbreviated as RKI, IC 50 (ROCK1) = 14.5 nM, and IC 50 (ROCK2) = 6.2 nM), and our recently developed set of HDAC inhibitors: Compound C6 (IC 50 (HDAC1) = 4.73 μM, IC 50 (HDAC3) = 1.86 μM, IC 50 (HDAC6) = 0.19 μM, IC 50 (HDAC8) = 2.44 μM); Compound C8 (IC 50 (HDAC1) = 0.41 μM, IC 50 (HDAC3) = 0.21 μM, IC 50 (HDAC6) = 0.12 μM, IC 50 (HDAC8) = 0.24 μM); Compound C9 (IC 50 (HDAC1) = 1.47 μM, IC 50 (HDAC3) = 3.47 μM, IC 50 (HDAC6) = 0.03 μM, IC 50 (HDAC8) = 0.71 μM). 31…”
Section: Resultsmentioning
confidence: 99%